Edwards Lifesciences (EW) Interest Coverage Ratio (2009 - 2017)
Edwards Lifesciences' quarterly Interest Coverage Ratio came in at 17.41 in Q4 2017, up 6.46% year-on-year from 16.36 in Q4 2016, and down 99.19% quarter-over-quarter from 2140.0 in Q3 2017.
Edwards Lifesciences has reported Interest Coverage Ratio for 4 years, with the latest figure at 17.41 in Q4 2017.
- For the quarter ending Q4 2017, Interest Coverage Ratio rose 6.46% year-over-year to 17.41; the trailing twelve-month figure through Sep 2018 stood at 56.46 (down 4.18% YoY), and the FY2025 full-year result was 61.97, down 11.0% from the prior year.
- Interest Coverage Ratio for Q4 2017 stood at 17.41, down from 2140.0 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 2140.0 in Q3 2017, with the low at 16.36 in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.98 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 17.41 |
| Sep 30, 2017 | 2,140.00 |
| Jun 30, 2017 | 172.14 |
| Mar 31, 2017 | 124.29 |
| Dec 31, 2016 | 16.36 |
| Sep 30, 2016 | 89.95 |
| Jun 30, 2016 | 86.00 |
| Mar 31, 2016 | 79.29 |
| Dec 31, 2010 | 23.03 |
| Sep 30, 2010 | -168.50 |
| Jun 30, 2010 | 36.60 |
| Mar 31, 2010 | -313.50 |
| Dec 31, 2009 | 17.89 |
| Sep 30, 2009 | -94.00 |
| Jun 30, 2009 | -312.50 |